How to Buy Evolus Stock

Evolus Inc

Evolus, Inc. , a performance beauty company, provides medical aesthetic products for physicians and their patients in the United States.

Evolus stock last closed at $10.38, down 3.8% from the previous day, and has decreased 11.43% in one year. It has overperformed other stocks in the Drug Manufacturers - Specialty & Generic industry by 0.45 percentage points. Evolus stock is currently +19.72% from its 52-week low of $8.67, and -41.75% from its 52-week high of $17.82.

At the moment, there are 63.59M shares of EOLS outstanding. The market capitalization of EOLS is $660.03M. In the past 24 hours, 657,803 EOLS shares were traded.

How to Buy Evolus Stock

Not sure how to invest in Evolus stock? Here's how.

  1. Decide where to buy Evolus stock: You need to pick a stock brokerage, but don't worry - we've researched dozens of online stock brokerages and apps to help you decide where to buy Evolus stock.
  2. Open your brokerage account: Sign up for 0% fee trading with the highest-rated brokerage we've selected.
  3. Fund your investment account: Choose your payment method and add your details.
  4. Evaluate Evolus stock: The Evolus ticker symbol is EOLS. Is Evolus stock a good investment? Should you buy shares of EOLS? How do EOLS's underlying business fundamentals look? Do top analysts think Evolus is a good buy? Why has EOLS's stock price moved recently? (Hint: Our stock market research tools can help you figure out if EOLS is a good stock to buy).
  5. Execute your EOLS purchase: Decide if you will purchase EOLS shares at the current market price or use a limit order to buy EOLS stock at a specific price.
  6. Keep tabs on your investment in EOLS: Create a watchlist to monitor your investment in Evolus stock.

Step 1: Decide where to buy Evolus stock

You will need a brokerage account in order to access the NASDAQ market and buy EOLS stock.

A brokerage account is an investment account that allows you to buy and sell a number of investments, such as stocks, bonds, mutual funds, and ETFs.

Our preferred brokerage: eToro

Based on our analysis, eToro is the best stock brokerage. eToro gives you:

  • You can invest in stocks with zero commissions: Invest without commissions.
  • Buy fractional shares: Even if you don't have the money to buy a full share, you can still buy the stock.
  • Access to global markets: From Technology to Financial Services, New York to Tokyo (for US users, only US stocks are available) — you can fill your portfolio with stocks from the globe's leading stock exchanges.
  • Social investing: eToro boasts a community of more than 20 million users worldwide. Talk to, learn from, and copy the unique crypto portfolios of other investors.
  • Security: eToro is a regulated and licensed brokerage platform.
  • Buy other assets: Such as ETFs and cryptocurrencies.

Get $10 towards your purchase of shares by signing up for an account with eToro now. This offer is only for US users.

Open eToro Account
eToro securities trading is offered by eToro USA Securities, Inc. (“the BD”), member of FINRA and SIPC. Cryptocurrency is offered by eToro USA LLC (“the MSB”) (NMLS: 1769299) and is not FDIC or SIPC insured. Investing involves risk, and content is provided for educational purposes only, does not imply a recommendation, and is not a guarantee of future performance. https://www.wallstreetzen.com is not an affiliate and may be compensated if you access certain products or services offered by the MSB and/or the BD.

Step 2: Open your brokerage account

Now that you've selected your brokerage, it's time to fill out some personal info so you can buy EOLS stock today.

How to Start a New Investment Account on eToro

  1. Click here to get started.
    eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
  2. Input your personal data to open a new brokerage account.
  1. Send your info by hitting the "Create Account" button.
  2. Get started with eToro today
    eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.

Step 3: Fund your investment account

Now that you have created your account on the best stock app to use, you can securely and quickly fund your account:

Check out the tutorial below if you need help transferring funds into your new investment account.

Get started with eToro today
eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.

Step 4: Evaluate Evolus stock

After you have chosen the best place to buy Evolus stock, it's absolutely critical to analyze their stock before you invest, so you truly wrap your head around the risk as well as the opportunity.

Evolus Numbers

EOLS Price
$10.38
1w %
1.07%
1y %
-11.43%
5y %
144.81%
P/E
-12.81x
P/B
119.53x
P/S
2.42x
PEG
N/A
Revenue
$266.27M
Earnings
-$50.42M
Fore. Rev. Growth
30.35%
Fore. Earn. Growth
N/A
Market Cap
$660.03M
Next Earnings
May 5, 2025
Next Dividend
N/A

EOLS Fundamentals

WallStreetZen was designed to help average investors do better fundamental analysis quickly.

You can view all of the due diligence checks on EOLS's stock page.

What is the fair value of EOLS stock?

Investors use a variety of different financial metrics, analyses, models, and charts to gauge EOLS's fair value.

Using relative valuations methods:

  • EOLS may be overvalued based on its P/B ratio of 119.53x, relative to Drug Manufacturers - Specialty & Generic industry P/B ratio of 1.98x

You can access more valuation analysis on EOLS's stock here.

EOLS Financial Health Summary

Signs that EOLS is financially healthy:

  • EOLS profit margin has gone up from -30.5% to -18.9% in the past year.
  • EOLS has cash burn of 22822000. It has sufficient cash and short-term investments to cover this for at least one year.
  • There are more short-term assets than short-term liabilities on the EOLS balance sheet.
  • EOLS has $86.95M in cash and short term investments. This is enough to cover its annual cash burn of $22.82M.

Signs that EOLS is not financially healthy:

  • EOLS has a relatively high debt to equity ratio of 41.12.
  • There are more long-term liabilities than short-term assets on the EOLS balance sheet.
  • Total EOLS debt is higher than 5 years ago, relative to shareholder equity.

Is it a good time to buy Evolus stock, according to analysts?

Out of 4 Wall Street analysts who track EOLS, the consensus analyst rating on Evolus is a Strong Buy

It's important to keep in mind that analyst ratings are not stock recommendations, nor are they investment advice.

You can dig deeper into what analysts are forecasting on the Evolus stock forecast page.

EOLS Momentum

SMA10
10.07
SMA20
11.06
SMA50
12.72
SMA100
12.44
SMA200
13.52
MACD
-0.75
MACD Signal
-0.79
MACD Histogram
0.04
RSI
41.23
Stochastic %K
45.75
Stochastic %D
43.36
StochRSI %K
92.44
StochRSI %D
93.4

EOLS Growth Numbers

Last year, EOLS revenue was $266.27M. In the past 5 year, EOLS's revenue has increased by 50.12% per year. This was faster than the Drug Manufacturers - Specialty & Generic industry average of 7.89%.

You can analyze EOLS's earnings and revenue performance here.

Are EOLS executives and large shareholders buying or selling the stock?

Over the last year, insiders at EOLS have sold more shares than they have bought.

David Moatazedi, President and Chief Executive Officer of EOLS, was the latest EOLS insider to sell. They sold $77,512.40 worth of EOLS stock on Mar 27, 2025.

Learn more about who owns EOLS stock here.

Does EOLS stock generate passive income?

No, Evolus doesn't provide an income stream by paying out dividends.

EOLS Social Trading Data

One of the reasons eToro is our highest-rated brokerage is because of its social trading community.

Click below to see what other community members have to say.

Step 5: Execute your EOLS purchase

There are two main options:

  • Market order: A market order is an order to buy or sell a stock at the best possible price.
    Market orders are generally sufficient.
  • Limit order: A limit order is an order to buy or sell a security at a specific price (or better).
    If you want to be certain you're buying or selling at an exact dollar amount, use a limit order.

Click the Open button and your broker will execute your order.

If you want more info about investing in stocks on eToro, watch the how to video below:

Open eToro Account

Step 6: Keep tabs on your investment in EOLS

Now that you own some EOLS shares, you'll want to keep up with your investment.

Create a watchlist to keep track of your EOLS stock.

EOLS Feed

How to Buy Stock in Evolus

To summarize, here are the 6 steps you need to take to buy Evolus stock right now:

  1. Decide where to buy Evolus stock
  2. Open your brokerage account
  3. Fund your investment account
  4. Evaluate Evolus stock
  5. Execute your EOLS purchase
  6. Keep tabs on your investment in EOLS

If you need a brokerage account, eToro is our recommended venue.

Get Started with eToro Today
eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.

If you want to keep an eye on your new investment in Evolus, create a watchlist today.

NASDAQ: EOLS
$10.38-0.41 (-3.8%)
Updated Apr 21, 2025
Open eToro Account
Your capital is at risk.
NASDAQ: EOLS
$10.38-0.41 (-3.8%)
Updated Apr 21, 2025
Open eToro Account
Your capital is at risk.

FAQ

How much does it cost to buy one Evolus share?

As of Apr 21, 2025, it costs $10.38 to buy one share of Evolus stock.

Remember, eToro's fractional share buying allows you to buy partial shares of stocks and ETFs. Even if you only have $5, you can buy 0.482 shares of EOLS.

Get Started with eToro Today
eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.

Is now a good time to buy Evolus stock?

According to 4 Wall Street analysts who monitor Evolus, their consensus recommendation is to buy Evolus stock.

What is the best way to buy Evolus stock?

One way to place an order for Evolus stock is with a brokerage account.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.